Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study
Author:
Affiliation:
1. The Jikei University School of Medicine Tokyo Japan
2. Tokyo Yamate Medical Center Tokyo Japan
3. Jichi Medical University Tochigi Japan
4. AbbVie Tokyo Japan
5. AbbVie Farmacéuticos SA de CV Mexico City Mexico
Funder
AbbVie
Forskningsrådet om Hälsa, Arbetsliv och Välfärd
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.13409
Reference22 articles.
1. Psoriasis: epidemiology, natural history, and differential diagnosis;Basko‐Plluska JL;Psoriasis: Targets Ther,2012
2. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
3. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database
4. Prevalence of dermatological disorders in Japan: A nationwide, cross-sectional, seasonal, multicenter, hospital-based study
5. Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Active Tuberculosis in a Patient Receiving Adalimumab for Psoriatic Arthritis and Chemoprophylaxis for Latent Tuberculosis Infection;Journal of Nippon Medical School;2023-12-25
2. English version of Japanese guidance for use of biologics for psoriasis (the 2022 version);The Journal of Dermatology;2022-12-29
3. Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE study;Journal of Dermatological Science;2022-03
4. Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review;Archives of Dermatological Research;2022-01-20
5. Efficacy and safety of immune checkpoint inhibitors and cytokine therapy in autoimmune diseases;Translational Autoimmunity;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3